common.study.topics.clinical

Optimizing Anesthesia for Post Partum Tubal Ligations

common.study.values.description

Optimizing Anesthesia for Post Partum Tubal Ligations

In this study, the investigators will compare CLOROTEKALAR (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible for enrollment in this study. Outcomes measured will include: ability to achieve an adequate level required for surgery (T6), rate of epidural activation, and duration of the block. The investigators hope to determine the usefulness of each drug using the EVE technique in the setting of PPBTL.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Chloroprocaine

Adding 5 cc 1% Chloroprocaine with 10 cc sterile saline in the epidural

Drug - Bupivacaine

1 cc of 0.5% bupivacaine with 15 mcg fentanyl 10 cc of sterile saline in the epidural

participant.views.study.view.additional

participant.views.study.view.scientific-title

Comparing 1% Spinal Chloroprocaine to Low-dose Bupivacaine Using the Epidural Volume Extension Technique for Post-Partum Tubal Ligation

common.study.values.clinical-trial-id

NCT03993314

participant.views.study.view.id

ejRWve